The DOI matches its Crossref record; 65 of the 67 references it cites were found in a registry or an index.
Dense low density lipoprotein subspecies with diminished oxidative resistance predominate in combined hyperlipidemia.
Open accessAbstract
Patients presenting combined hyperlipidemia (CHL) display an elevated risk of coronary heart disease. The atherogenic lipoprotein particles implicated in this disorder remain ill defined. We determined the qualitative and quantitative characteristics of the density distribution of low density lipoprotein (LDL) particle subspecies in nine subjects defined phenotypically as presenting CHL, and under strict dietary control. Seven CHL patients possessed familial antecedents of premature coronary heart disease; none were E2E2 homozygotes. Five LDL subspecies were isolated by density gradient ultracentrifugation in the density range 1.019-1.063 g/ml. In all patients, the LDL profile was skewed towards the dense subspecies (LDL-4, d 1.039-1.050 g/ml and LDL-5, d 1.050-1.063 g/ml), representing 47% of total LDL mass; by contrast, these subspecies accounted for only 30% of LDL mass in five normolipidemic subjects (P < 0.01). In addition, plasma LDL mass concentrations were some twofold higher in CHL patients as compared to normolipidemic subjects. The % mass of LDL-4 was positively correlated with plasma triglyceride and apoB levels. LDL-2 and LDL-3 in CHL patients were triglyceride-enriched (11.9 and 7.2%, respectively) as compared to the corresponding subspecies in normolipidemic subjects (6.6 and 3.7%, respectively; P < 0.05 in each case). LDL particle size decreased with increase in density in both groups; however, significant differences were found between corresponding LDL subspecies (LDL-1, -3, -4, and -5) in CHL patients and normolipidemic subjects, a finding suggestive of dissimilar molecular organization, despite correspondence in hydrated density. The copper-induced oxidative modification of LDL subspecies was assessed by determination of conjugated diene formation. In both groups, LDL-5 was distinct in exhibiting a marked diminution in oxidative resistance as indicated by a significant reduction (P < 0.01) in mean lag time. The oxidative susceptibility of LDL subspecies in both groups was independent of vitamin E content when expressed as the ratio vitamin E/LDL mass, although dense LDL in CHL patients tended to be deficient in this antioxidant. The diminished oxidative resistance of dense LDL subspecies could not be accounted for by enrichment in polyunsaturated fatty acids in either group. These studies suggest that in consequence of their elevated circulating concentration and diminished oxidative resistance, dense LDL subspecies represent putative atherogenic subspecies in combined hyperlipidemia.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Larger LDL particles may reduce CV risk because small dense LDL is associated with increased atherogenicity [55].”
Citations
Cites
PROTEIN MEASUREMENT WITH THE FOLIN PHENOL REAGENT
Lowry, O. H., Rosebrough, N., Farr, A. L., & Randall, R. (1951) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)52451-6 · Cited by 316,394
Friedewald, W. T., Levy, R. I., & Fredrickson, D. S. (1972) · Clinical Chemistry · doi:10.1093/clinchem/18.6.499 · Cited by 32,423
Enzymatic determination of total serum cholesterol.
Allain, C. C., Poon, L. S., Chan, C. S. G., Richmond, W., & Fu, P. C. (1974) · Clinical Chemistry · doi:10.1093/clinchem/20.4.470 · Cited by 9,845
The Metabolic Basis of Inherited Disease.
(1988) · Annals of Internal Medicine · doi:10.7326/0003-4819-108-3-503_7 · Cited by 7,807
Epstein, F. H., Steinberg, D. I., Parthasarathy, S., Carew, T. E., Khoo, J. C., & Witztum, J. L. (1989) · New England Journal of Medicine · doi:10.1056/nejm198904063201407 · Cited by 6,425
Helsinki Heart Study: Primary-Prevention Trial with Gemfibrozil in Middle-Aged Men with Dyslipidemia
Frick, M. H., Elo, O., Haapa, K., Heinonen, O. P., Heinsalmi, P., Helo, P., Huttunen, J. K., Kaitaniemi, P., Koskinen, P., Manninen, V., et al. (1987) · New England Journal of Medicine · doi:10.1056/nejm198711123172001 · Cited by 3,881
Abell, L. L., Levy, B. B., Brodie, B. B., & Kendall, F. E. (1952) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)50907-3 · Cited by 3,085
The Metabolic Basis of Inherited Disease.
(1983) · Annals of Internal Medicine · doi:10.7326/0003-4819-99-3-425_3 · Cited by 2,693
Continuous Monitoring ofin VztroOxidation of Human Low Density Lipoprotein
Esterbauer, H., Striegl, G., Puhl, H., & Rotheneder, M. (1989) · Free Radical Research Communications · doi:10.3109/10715768909073429 · Cited by 1,790
Blankenhorn, D. H. (1987) · JAMA · doi:10.1001/jama.1987.03390230069027 · Cited by 1,654
Research works printed but not linked: 2
- Steinberg, 1989, Modifications of low-density lipoprotein that increase its atherogenicity, N. Engl. J. Med., 320, 915
- Esterbauer, 1989, Continuous monitoring of in vitro oxidation of human low density lipoprotein, Free Rod. Res. Commun., 6, 67
Cited by
Sorted by citations
Lamarche, B., Tchernof, A., Moorjani, S., Cantin, B., Dagenais, G. R., Lupien, P. J., & Despre´s, J.-P. (1997) · Circulation · doi:10.1161/01.cir.95.1.69 · Cited by 1,077
Metabolic origins and clinical significance of LDL heterogeneity
Berneis, K. K., & Krauss, R. M. (2002) · Journal of Lipid Research · doi:10.1194/jlr.r200004-jlr200 · Cited by 896
Nicotinic acid: the broad‐spectrum lipid drug. A 50th anniversary review
Carlson, L. A. (2005) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2005.01528.x · Cited by 591
Hoogeveen, R. C., Gaubatz, J. W., Sun, W., Dodge, R. C., Crosby, J. R., Jiang, J., Couper, D., Virani, S. S., Kathiresan, S., Boerwinkle, E., et al. (2014) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.114.303284 · Cited by 507
Postprandial lipoproteins and progression of coronary atherosclerosis
Karpe, F., Steiner, G. A., Uffelman, K. D., Olivecrona, T., & Hamsten, A. (1994) · Atherosclerosis · doi:10.1016/0021-9150(94)90085-x · Cited by 485
Barter, P. J., Ballantyne, C. M., Carmena, R., Cabezas, M. C., Chapman, M. J., Couture, P., Graaf, J. D., Durrington, P. N., Færgeman, O., Frohlich, J., et al. (2006) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2006.01616.x · Cited by 465
Self-citationIn vivo regulation of lipolysis in humans.
Coppack, S. W., Jensen, M. D., & Miles, J. M. (1994) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)41207-6 · Cited by 411
Sniderman, A. D., Scantlebury, T., & Cianflone, K. (2001) · Annals of Internal Medicine · doi:10.7326/0003-4819-135-6-200109180-00014 · Cited by 331
Durrington, P. N. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14234-1 · Cited by 316
Oxidative stress and normal pregnancy
Toescu, V., Nuttall, S. L., Martin, U., Kendall, M. J., & Dunne, F. (2002) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2002.01638.x · Cited by 285
Statins in atherosclerosis: lipid-lowering agents with antioxidant capabilities
Rosenson, R. S. (2003) · Atherosclerosis · doi:10.1016/s0021-9150(03)00239-9 · Cited by 264
Galeano, N. F., Al-Haideri, M. T., Keyserman, F., Rumsey, S. C., & Deckelbaum, R. J. (1998) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)32551-7 · Cited by 229
Niacin and fibrates in atherogenic dyslipidemia: pharmacotherapy to reduce cardiovascular risk
Chapman, M. J., Redfern, J. S., McGovern, M. E., & Giral, P. (2010) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2010.01.008 · Cited by 227
Self-citationKwiterovich, P. O. (2002) · The American Journal of Cardiology · doi:10.1016/s0002-9149(02)02749-2 · Cited by 208
Iribarren, C., Folsom, A. R., Jacobs, D. R., Gross, M. D., Belcher, J. D., & Eckfeldt, J. H. (1997) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.17.6.1171 · Cited by 201
PAF-Degrading Acetylhydrolase Is Preferentially Associated With Dense LDL and VHDL-1 in Human Plasma
Tselepis, A. D., Dentan, C., Karabina, S.-A. P., Chapman, M. J., & Ninio, E. (1995) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.15.10.1764 · Cited by 198
Self-citationCouillard, C., Ruel, G., Archer, W. R., Pomerleau, S., Bergeron, J., Couture, P., Lamarche, B., & Bergeron, N. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-2438 · Cited by 202
Guérin, M., Bruckert, É., Dolphin, P. J., Turpin, G., & Chapman, M. J. (1996) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.16.6.763 · Cited by 195
Self-citationGoulinet, S., & Chapman, M. J. (1997) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.17.4.786 · Cited by 193
Self-citationTribble, D. L., Rizzo, M., Chait, A., Lewis, D. M., Blanche, P. J., & Krauss, R. M. (2001) · The American Journal of Medicine · doi:10.1016/s0002-9343(00)00700-2 · Cited by 185
Galeano, N. F., Milne, R. W., Marcel, Y. L., Walsh, M. T., Levy, E. H., Ngu'yen, T. D., Gleeson, A. M., Arad, Y., Witte, L., & Al-Haideri, M. T. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)42379-9 · Cited by 181
Reaven, P. D., Grasse, B. J., & Tribble, D. L. (1994) · Arteriosclerosis and Thrombosis A Journal of Vascular Biology · doi:10.1161/01.atv.14.4.557 · Cited by 181
Coni, E., Benedetto, R. D., Pasquale, M. D., Masella, R., Modesti, D., Mattei, R., & Carlini, E. A. (2000) · Lipids · doi:10.1007/s11745-000-0493-2 · Cited by 180
Reaven, P. D., Herold, D. A., Barnett, J., & Edelman, S. V. (1995) · Diabetes Care · doi:10.2337/diacare.18.6.807 · Cited by 169
Tribble, D. L., van den Berg, J. J. M., Motchnik, P. A., Ames, B. N., Lewis, D. M., Chait, A., & Krauss, R. M. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.3.1183 · Cited by 163
Oscarsson, J., & Hurt-Camejo, E. (2017) · Lipids in Health and Disease · doi:10.1186/s12944-017-0541-3 · Cited by 158
Sevanian, A., Hwang, J., Hodis, H. N., Cazzolato, G., Avogaro, P., & Bittolo-Bon, G. (1996) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.16.6.784 · Cited by 151
Goff, W. L., Guérin, M., & Chapman, M. J. (2004) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2003.10.001 · Cited by 148
Self-citationMcNamara, J. R., Small, D. M., Li, Z., & Schaefer, E. J. (1996) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)37557-x · Cited by 147
Lund‐Katz, S., Laplaud, P. M., Phillips, M. C., & Chapman, M. J. (1998) · Biochemistry · doi:10.1021/bi980828m · Cited by 143
Self-citationOxidation of low density lipoproteins in the pathogenesis of atherosclerosis
Holvoet, P., & Collen, D. (1998) · Atherosclerosis · doi:10.1016/s0021-9150(97)00305-5 · Cited by 136
Molecular structure of low density lipoprotein: current status and future challenges
Prassl, R., & Laggner, P. (2008) · European Biophysics Journal · doi:10.1007/s00249-008-0368-y · Cited by 122
EDUCATION AND AGE-RELATED COGNITIVE DECLINE: THE CONTRIBUTION OF MENTAL WORKLOAD
Bosma, H., van Boxtel, M. P. J., Ponds, R., Houx, P. J., & Jolles, J. (2003) · Educational Gerontology · doi:10.1080/10715769800300191 · Cited by 121
Noonan, J. E., Jenkins, A. J., Ma, J., KEECH, A. C., Wang, J. J., & Lamoureux, E. L. (2013) · Diabetes · doi:10.2337/db13-0800 · Cited by 120
Diagnosis and treatment of apolipoprotein B dyslipoproteinemias
Sniderman, A. D., Couture, P., & Graaf, J. D. (2010) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2010.50 · Cited by 118
Rajman, I., Kendall, M. J., Cramb, R., Holder, R. L., Salih, M., & GAMMAGE, M. D. (1996) · Atherosclerosis · doi:10.1016/0021-9150(96)05881-9 · Cited by 108
Dallinga‐Thie, G. M., Bu, X. D., Trip, M. V. L.-S., Rotter, J. I., Lusis, A. J., & de Bruin, T. W. A. (1996) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)37642-2 · Cited by 108
Electronegative low-density lipoprotein: Origin and impact on health and disease
Mello, A. P. D. Q., da Silva, I. T., Abdalla, D. S. P., & Damasceno, N. R. T. (2011) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2010.12.028 · Cited by 105
Younis, N. N., Charlton-Menys, V., Sharma, R., Soran, H., & Durrington, P. N. (2008) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2008.04.036 · Cited by 104
Skoglund-Andersson, C., Tang, R., Bond, M. G., Fairé, U. D., Hamsten, A., & Karpe, F. (1999) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.19.10.2422 · Cited by 104
Dual signaling evoked by oxidized LDLs in vascular cells
Nègre‐Salvayre, A., Augè, N., Camaré, C., Bacchetti, T., Ferretti, G., & Salvayre, R. (2017) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2017.02.006 · Cited by 101
Chowienczyk, P., Watts, G. F., Wierzbicki, A. S., Cockcroft, J. R., Brett, S., & Ritter, J. M. (1997) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(97)00033-8 · Cited by 92
Cassader, M., Gambino, R., Musso, G., Depetris, N., Mecca, F., Cavallo‐Perin, P., Pacini, G., Rizzetto, M., & Pagano, G. (2001) · Lipids · doi:10.1007/s11745-001-0822-5 · Cited by 88
Evidences of the cardioprotective potential of fruits: The case of cranberries
Ruel, G., & Couillard, C. (2007) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.200600286 · Cited by 86
Lesnik, P., Vonica, A., Guérin, M., Moreau, M., & Chapman, M. J. (1993) · Arteriosclerosis and Thrombosis A Journal of Vascular Biology · doi:10.1161/01.atv.13.7.1066 · Cited by 86
Self-citationJin, J.-L., Zhang, H.-W., Cao, Y.-X., Liu, H.-H., Hua, Q., Li, Y.-F., Zhang, Y., Wu, N.-Q., Zhu, C.-G., Xu, R.-X., et al. (2020) · Cardiovascular Diabetology · doi:10.1186/s12933-020-01015-6 · Cited by 82
Interactions Between Glucose and FFA Metabolism in Man
Saloranta, C., & Groop, L. (1996) · Diabetes/Metabolism Reviews · doi:10.1002/(sici)1099-0895(199603)12:1 · Cited by 37
Chancharme, L., Thérond, P., Nigon, F., Lepage, S., Couturier, M., & Chapman, M. J. (1999) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.19.3.810 · Cited by 80
Self-citationAustin, M. A., & Hokanson, J. E. (1994) · Medical Clinics of North America · doi:10.1016/s0025-7125(16)30178-x · Cited by 78
LDL physical and chemical properties in familial combined hyperlipidemia
Hokanson, J. E., Krauss, R. M., Albers, J. J., Austin, M. A., & Brunzell, J. D. (1995) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.15.4.452 · Cited by 76
Dyslipidemia in diabetes mellitus
Yoshino, G., Hirano, T., & Kazumi, T. (1996) · Diabetes Research and Clinical Practice · doi:10.1016/0168-8227(96)01263-6 · Cited by 75
Morena-Carrere, M., Cristol, J., DANTOINE, T. F., Carbonneau, M., Descomps, B., & Canaud, B. (2000) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/15.3.389 · Cited by 72
LDL particle size: an important drug target?
Rajman, I., Eacho, P. I., Chowienczyk, P. J., & Ritter, J. M. (1999) · British Journal of Clinical Pharmacology · doi:10.1046/j.1365-2125.1999.00991.x · Cited by 51
Associations of low density lipoprotein particle composition with atherogenicity
Lada, A. T., & Rudel, L. L. (2004) · Current Opinion in Lipidology · doi:10.1097/00041433-200402000-00005 · Cited by 71
Chen, G. C., Liu, W., Duchateau, P. N., Allaart, J., Hamilton, R. L., Mendel, C. M., Lau, K., Hardman, D. A., Frost, P. H., & Malloy, M. J. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)62020-x · Cited by 71
Dietary Mono- and Polyunsaturated Fatty Acids Similarly Affect LDL Size in Healthy Men and Women
Kratz, M., Gülbahçe, E., von Eckardstein, A., Cullen, P., Cignarella, A., Assmann, G., & Wahrburg, U. (2002) · Journal of Nutrition · doi:10.1093/jn/132.4.715 · Cited by 69
Defects of lipoprotein metabolism in familial combined hyperlipidaemia
Graaf, J. D., & Stalenhoef, A. F. H. (1998) · Current Opinion in Lipidology · doi:10.1097/00041433-199806000-00002 · Cited by 68
Damasceno, N. R. T., Sevanian, A., Apolinário, E., Oliveira, J. M. A., Fernandes, I., & Abdalla, D. S. P. (2005) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2005.09.014 · Cited by 67
Sánchez‐Quesada, J. L., Pérez, A., Caixàs, A., Rigla, M., Payés, A., Benı́tez, S., & Ordóñez‐Llanos, J. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.7.7692 · Cited by 66
Tribble, D. L., Krauss, R. M., Lansberg, M. G., Thiel, P. M., & van den Berg, J. J. M. (1995) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)40052-5 · Cited by 66
Ziouzenkova, O., Winklhofer‐Roob, B. M., Puhl, H., Roob, J. M., & Esterbauer, H. (1996) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)37558-1 · Cited by 62
The effects of menopause on the serum lipid profile of normal females of South East Nigeria.
Igweh, J. C., Nwagha, I. U., & Okaro, J. M. (2005) · PubMed · Cited by 61
Age-independent oxidative stress in elderly patients with non-insulin-dependent diabetes mellitus
Nuttall, S. L. (1999) · QJM · doi:10.1093/qjmed/92.1.33 · Cited by 60
Bruckert, É., Dejager, S., & Chapman, M. J. (1993) · Atherosclerosis · doi:10.1016/0021-9150(93)90071-2 · Cited by 59
Self-citationLoane, E., Nolan, J. M., & Beatty, S. (2010) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.09-4878 · Cited by 59
Scheffer, P. G., Bos, G., Volwater, H. G. F. M., Dekker, J. M., Heine, R. J., & Teerlink, T. (2003) · Diabetic Medicine · doi:10.1046/j.1464-5491.2003.00975.x · Cited by 58
Association of oxidative stress and PON1 with LDL and HDL particle size in middle‐aged subjects
Vekić, J., Kotur‐Stevuljevic, J., Jelić‐Ivanović, Z., Spasić, S., Spasojević‐Kalimanovska, V., Topić, A., Zeljković, A., Stefanović, A., & Zunic, G. (2007) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2007.01849.x · Cited by 55
Desager, J., Horsmans, Y., Vandenplas, C., & Harvengt, C. (1996) · Atherosclerosis · doi:10.1016/0021-9150(96)05859-5 · Cited by 54
Metabolism of phytol to phytanic acid in the mouse, and the role of PPARα in its regulation
Gloerich, J., van den Brink, D. M., Ruiter, J. P. N., van Vlies, N., Vaz, F. M., Wanders, R. J. A., & Ferdinandusse, S. (2006) · Journal of Lipid Research · doi:10.1194/jlr.m600050-jlr200 · Cited by 53
Laplaud, P. M., Lelubre, A., & Chapman, M. J. (1997) · Fundamental and Clinical Pharmacology · doi:10.1111/j.1472-8206.1997.tb00166.x · Cited by 53
Self-citationMcEneny, J., O’Kane, M., Moles, K. W., McMaster, C., McMaster, D., Mercer, C., Trimble, E. R., & Young, I. S. (2000) · Diabetologia · doi:10.1007/s001250051333 · Cited by 52
Wang, L., Walsh, M. T., & SMALL, D. M. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0602213103 · Cited by 51
Carmena, R., Ascaso, J. F., Camejo, G., Varela, G., Hurt‐Camejo, E., Ordovás, J. M., Martínez-Valls, J. F., Bergstöm, M., & Wallin, B. (1996) · Atherosclerosis · doi:10.1016/0021-9150(96)05882-0 · Cited by 51
Small, dense low-density lipoprotein as a risk factor for coronary heart disease
Austin, M. A. (1994) · International Journal of Clinical & Laboratory Research · doi:10.1007/bf02592460 · Cited by 48
Kwon, S. W., Yoon, S., Kang, T. S., Kwon, H. M., Kim, J., Rhee, J., Lee, S.-J., Park, J., Lim, J. Y., Yoon, Y. W., et al. (2006) · Yonsei Medical Journal · doi:10.3349/ymj.2006.47.3.405 · Cited by 47
Grammer, T., Kleber, M., März, W., Silbernagel, G., Siekmeier, R., Wieland, H., Pilz, S., Tomaschitz, A., Koenig, W., & Scharnagl, H. (2015) · European Heart Journal · doi:10.1093/eurheartj/ehu055 · Cited by 42
Carotenoid Composition and Antioxidant Potential in Subfractions of Human Low-Density Lipoprotein
Lowe, G. M., Bilton, R. F., Davies, I. G., FORD, T. C., Billington, D., & Young, A. J. (1999) · Annals of Clinical Biochemistry International Journal of Laboratory Medicine · doi:10.1177/000456329903600304 · Cited by 46
Byrne, D. J., Neil, H. A. W., Vallance, D. T., & WINDER, A. F. (1999) · Clinica Chimica Acta · doi:10.1016/s0009-8981(99)00063-7 · Cited by 45
Reaven, P. D. (1995) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/62.6.1483s · Cited by 45
Guérin, M., Dolphin, P. J., & Chapman, M. J. (1994) · Arteriosclerosis and Thrombosis A Journal of Vascular Biology · doi:10.1161/01.atv.14.5.679 · Cited by 45
Self-citationChen, H.-H., Hosken, B. D., Huang, M. T.-H., Gaubatz, J. W., Myers, C. L., Macfarlane, R. D., Pownall, H. J., & Yang, C.-Y. (2006) · Journal of Lipid Research · doi:10.1194/jlr.m500481-jlr200 · Cited by 44
Krychtiuk, K. A., Kastl, S., Pfaffenberger, S., Lenz, M. W., Hofbauer, S. L., Wonnerth, A., Koller, L., Katsaros, K. M., Pongratz, T., Goliasch, G., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0123367 · Cited by 44
Core lipid structure is a major determinant of the oxidative resistance of low density lipoprotein.
Schuster, B., Prassl, R., Nigon, F., Chapman, M. J., & Laggner, P. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.7.2509 · Cited by 42
Self-citationMcCall, M. R., Belle, M. L., Forte, T. M., Krauss, R. M., Takanami, Y., & Tribble, D. L. (1999) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/s0005-2760(98)00177-5 · Cited by 42
Genetics of LDL particle heterogeneity: from genetic epidemiology to DNA-based variations.
Bossé, Y., Pérusse, L., & Vohl, M. (2004) · Journal of Lipid Research · doi:10.1194/jlr.r400002-jlr200 · Cited by 41
Zitoun, D., Bara, L., Basdevant, A., & Samama, M. M. (1996) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.16.1.77 · Cited by 41
Atherogenic lipoprotein parameters in patients with aggressive periodontitis
Rufail, M. L., Schenkein, H. A., Koertge, T. E., Best, A. M., Barbour, S. E., Tew, J. G., & van Antwerpen, R. (2007) · Journal of Periodontal Research · doi:10.1111/j.1600-0765.2007.00973.x · Cited by 40
Makoveichuk, E., Lõokene, A., & Olivecrona, G. (1998) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1998.9596 · Cited by 39
Apolipoprotein B as the best predictor of coronary artery disease in Iranian normolipidemic patients
Haidari, M., Moghadam, M., Chinicar, M., Ahmadieh, A., & Doosti, M. (2001) · Clinical Biochemistry · doi:10.1016/s0009-9120(01)00192-8 · Cited by 38
Raveh, O., Pinchuk, I., Schnitzer, E., FAINARU, M., Schafer, Z., & Lichtenberg, D. A. (2000) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(00)00332-4 · Cited by 38
Atherogenic lipoproteins and diabetes mellitus
Yoshino, G., Hirano, T., & Kazumi, T. (2002) · Journal of Diabetes and its Complications · doi:10.1016/s1056-8727(01)00199-4 · Cited by 38
Schlüssel, E., Preibisch, G., Piitter, S., & Elstner, E. F. (1995) · Zeitschrift für Naturforschung C · doi:10.1515/znc-1995-9-1017 · Cited by 38
The Atherogenic Significance of an Elevated Plasma Triglyceride Level
Ooi, T. C., & Ooi, D. S. (1998) · Critical Reviews in Clinical Laboratory Sciences · doi:10.1080/10408369891234255 · Cited by 37
Ohta, T., Saku, K., Takata, K., & Adachi, N. (1999) · European Journal of Pediatrics · doi:10.1007/s004310051154 · Cited by 38
Oxidation of LDL and their subfractions: Kinetic aspects and CoQ10 content
Alleva, R., Tomasetti, M., Bompadre, S., & Littarru, G. P. (1997) · Molecular Aspects of Medicine · doi:10.1016/s0098-2997(97)00039-3 · Cited by 38
Smilde, T. J. (2001) · The Netherlands Journal of Medicine · doi:10.1016/s0300-2977(01)00155-3 · Cited by 38
Sirtori, C. R., Calabresi, L., Pisciotta, L., Cattin, L., Pauciullo, P., Montagnani, M., Manzato, E., Bon, G. B., & Fellin, R. (2005) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2004.08.001 · Cited by 37
Copper-Catalyzed Oxidation Mediates PAF Formation in Human LDL Subspecies
Tsoukatos, D. C., Arborati, M., Liapikos, T. A., Clay, K. L., Murphy, R. C., Chapman, M. J., & Ninio, E. (1997) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.17.12.3505 · Cited by 37
Self-citationPerugini, C., Bagnati, M., Cau, C., Bordone, R. P., Zoppis, E., Paffoni, P., Re, R., Albano, E., & Bellomo, G. (2000) · Pharmacological Research · doi:10.1006/phrs.1999.0552 · Cited by 37
GENETICS OF LIPOPROTEIN DISORDERS
Davignon, J., & Genest, J. J. (1998) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(05)70024-4 · Cited by 37
Metadata
- Authors
- Dejager, S., Bruckert, E., & Chapman, M.
- Affiliations
- Inserm (FR)
- ORCID
- Chapman, MJ
- Venue
- Journal of Lipid Research
- Publisher
- Elsevier BV
- Published
- 1993-02
- Volume
- 34
- Issue
- 2
- Pages
- 295-308
- ISSN
- 0022-2275 (ISSN-L)
- OpenAlex
- W2135183362
- Cited by
- 237
- References
- 67
- Citations by year
- 2026: 2 · 2025: 3 · 2024: 3 · 2023: 1 · 2021: 2 · 2020: 3 · 2019: 1 · 2018: 2 · 2017: 3 · 2016: 2 · 2015: 2 · 2014: 2 · 2013: 2 · 2012: 5
- FWCI
- 24.34
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Journal of Lipid Research (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Cholesterol and Lipid Metabolism
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipid metabolism and disorders
- Keywords
- mixed dyslipidemia, LDL particle size, LDL oxidation, copper-induced oxidation, conjugated dienes, vitamin E, atherogenic lipoproteins, apolipoprotein B, coronary heart disease risk, dietary management, familial hypercholesterolemia
- MeSH terms
- Adult, Centrifugation, Density Gradient, Chemistry, Physical, Humans, Hyperlipidemia, Familial Combined, Lipid Peroxides, Lipoproteins, LDL, Male, Middle Aged, Oxidation-Reduction, Particle Size, Vitamin E, Lipoprotein(a), Chemical Phenomena
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review